Received May 27, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
Ongoing fevers; This non-serious case was reported by a pharmacist via sales rep and described the occurrence of fever in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 2nd dose of Shingrix (unknown arm). On an unknown date, an unknown time after receiving Shingrix, the patient experienced fever (Verbatim: Ongoing fevers). The outcome of the fever was resolved. It was unknown if the reporter considered the fever to be related to Shingrix. It was unknown if the company considered the fever to be related to Shingrix. Additional Information: GSK Receipt Date: 23-MAY-2025 The pharmacist reported that ongoing fevers in the evening for two weeks following the second dose of Shingrix. The pharmacist reported that this was from a woman in her late 50s/early 60s. The fever was only in the evenings and lasted for a few weeks before dissipating.